Kno2

Kno2

Private
Boise, IdahoHealthcare & Life Scienceshttps://www.kno2.com

Last Round

Series A

Jul 14, 2021

Total Funding Raised

$15M

Company Overview

Kno2 is a developer of a cloud-based health information platform designed to facilitate the secure and electronic exchange of patient information. The company's technology connects the healthcare continuum by transforming unstructured medical data from sources like faxes and paper documents into a common, standards-based digital format. Kno2's network enables interoperability at scale, allowing physician practices, post-acute care providers, and other healthcare organizations to communicate clinical information without altering their existing workflows. The platform provides a single connection point to a network of EHRs, organizations, and interoperability frameworks, aiming to democratize healthcare communication.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Data Integration, EHR & EMR, API Management, Cloud Communications

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Keywords

healthcare interoperabilityInteroperability as a ServiceIaaSclinical document exchangehealthcare APIEHR integrationhealth information exchangeHIEhealthcare network aggregatorDirect Secure Messagingcloud faxingCarequality networkQualified Health Information NetworkQHINpost-acute care technologypatient data routing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kno2 Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kno2 Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJul 14, 2021

Key People

Founding team and executive leadership

Jon Elwell

CEO

Executive Team

Kno2 Investors

Notable investors and investment history

InvestorRounds
Health Enterprise PartnersSeries A
Allumia VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Attended CMS Health Technology Ecosystem national showcase.

  • Apr 3, 2026

    Alan Swenson appointed Chief of Staff and SVP of Network Strategy.

Kno2 Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kno2 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kno2's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoise, Idaho
Employee Range55
Year Founded2009
Last FundingJul 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.